Efficacy of 10% imidacloprid + 2.5% moxidectin topical solution (Advantage Multi® for Dogs) for the prevention of heartworm disease and infection all month long

被引：0
作者：
Dwight D. Bowman
Cameon M. Ohmes
Joseph A. Hostetler
Daniel J. Keil
Terry L. Settje
Samuel D. Charles
机构：
[1] Liberty Research Inc,Department of Microbiology and Immunology, College of Veterinary Medicine
[2] Bayer Animal Health,undefined
[3] Cornell University,undefined
来源：
Parasites & Vectors | / 10卷
关键词：
Advantage Multi® for Dogs; Heartworm disease; All-month protection; Forward protection; Persistent efficacy; 30-Day protection; Proactive prevention; Imidacloprid; moxidectin; Advocate®;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 29 条
[1]  
Samson-Himmelstjerna G(2003)Larvicidal and persistent efficacy of an imidacloprid and moxidectin topical formulation against endoparasites in cats and dogs Parasitol Res 90 S114-S115
[2]  
Von Epe C(2015)Moxidectin steady state prior to inoculation protects cats from subsequent, repeated infection with Parasit Vectors 8 107-130
[3]  
Schimmel A(2016)Protection of dogs against canine heartworm infection 28 days after four monthly treatments with Advantage Multi® for dogs Parasit Vectors 9 12-194
[4]  
Heine J(2007)Comparison of the pharmacokinetics of moxidectin and ivermectin after oral administration to beagle dogs Biopharm Drug Dispos 28 431-undefined
[5]  
Little SE(1992)Bioavailability of ivermectin administered orally to dogs Vet Res Commun 16 125-undefined
[6]  
Hostetler JA(2011)Comparative efficacy of four commercially available heartworm preventive products against the MP3 laboratory strain of Vet Parasitol 176 189-undefined
[7]  
Thomas JE(undefined)undefined undefined undefined undefined-undefined
[8]  
Bailey KL(undefined)undefined undefined undefined undefined-undefined
[9]  
Barrett A(undefined)undefined undefined undefined undefined-undefined
[10]  
Gruntmeir K(undefined)undefined undefined undefined undefined-undefined
123